Truist on Privia Health (PRVA): 'Improving growth visibility and a favorable risk-reward for LT investors' Apr 6, 2026 08:32AM
Piper Sandler: 'Privia Health Group Inc (PRVA) is a Name to Own for CY26' Mar 19, 2026 08:36AM
Citizens Reiterates Market Outperform Rating on Privia Health Group Inc (PRVA) Mar 19, 2026 05:12AM
Privia Health Group, Inc. (PRVA) Tops Q4 EPS by 21c, provides outlook Feb 26, 2026 05:19PM
Privia Health Group Inc (PRVA) PT Raised to $32 at Jefferies Feb 26, 2026 03:26PM


Feb 26, 2026 02:34PM Privia Health Group Inc (PRVA) PT Raised to $36 at Piper Sandler
Jan 8, 2026 04:30PM RBC Capital Starts Privia Health Group Inc (PRVA) at Outperform
Jan 6, 2026 04:57AM Privia Health Group (PRVA) Reiterated at Market Outperform by Citizens
Nov 12, 2025 06:43AM Privia Health Group Inc (PRVA) PT Raised to $34 at Canaccord Genuity
Nov 10, 2025 04:44AM Privia Health Group Inc (PRVA) PT Raised to $31 at Truist Securities
Nov 6, 2025 05:20PM Privia Health Group, Inc. (PRVA) Tops Q3 EPS by 24c; raises guidance
Nov 6, 2025 04:06PM Privia Health Group Inc (PRVA) PT Raised to $30 at Evercore ISI
Nov 6, 2025 01:10PM Privia Health Group Inc (PRVA) PT Raised to $34 at Citi
Sep 24, 2025 06:47AM Piper Sandler: 'We Would Be Buyers of PRVA on Evolent Care Partners Deal'
Sep 24, 2025 04:14AM Citizens JMP Reiterates Market Outperform Rating on Privia Health Group Inc (PRVA)
Sep 23, 2025 04:11PM Privia Health to acquire ACO business from Evolent for $100 million
Sep 23, 2025 04:10PM Evolent Health sells primary care unit to Privia for up to $113 million
Aug 29, 2025 04:04AM Privia Health Group Inc (PRVA) PT Raised to $30 at Citizens JMP
Aug 11, 2025 08:21AM Privia Health Group Inc (PRVA) PT Lowered to $35; Piper Sandler 'Buyers of Large 2Q25 Beat and Raise'
Jul 8, 2025 09:02AM Privia Health adds Lance Berberian to board with tech expertise
Jun 16, 2025 09:45AM TD Cowen on Privia Health Group Inc (PRVA): 'A Lot to Like'
May 8, 2025 06:24AM Privia Health Group, Inc. (PRVA) Tops Q1 EPS by 18c
Apr 28, 2025 05:37AM Citizens JMP Reiterates Market Outperform Rating on Privia Health Group Inc (PRVA)
Apr 9, 2025 10:09AM Evercore ISI Reiterates Outperform Rating on Privia Health Group Inc (PRVA)
Apr 1, 2025 06:55AM KeyBanc: 'Analysis of Hypothetical MSSP Deal Between PRVA and EVH'
Mar 25, 2025 03:15PM Privia Health Group, Inc (PRVA) April 22.50 puts active on 1K contracts
Mar 4, 2025 09:55AM Privia Health Group Inc (PRVA) PT Raised to $29 at Jefferies
Feb 28, 2025 06:52AM Privia Health Group Inc (PRVA) PT Raised to $30 at Canaccord Genuity
Feb 28, 2025 04:25AM Privia Health Group Inc (PRVA) PT Raised to $29 at Citizens JMP
Feb 27, 2025 05:38PM Privia Health Group Inc (PRVA) PT Raised to $40 at Piper Sandler
Feb 27, 2025 05:20PM Privia Health Group Inc (PRVA) PT Raised to $30 at TD Cowen
Feb 27, 2025 04:33PM Privia Health Group Inc (PRVA) PT Raised to $32 at Citi
Feb 27, 2025 06:24AM Privia Health Group, Inc. (PRVA) Tops Q4 EPS by 16c ; Offers Guidance
Jan 14, 2025 05:50AM KeyBanc Provides Healthcare Services Update: 'Positive Update from EVH Potentially the Most Impactful'
Jan 13, 2025 07:23AM Humana (HUM), Others Gain After Proposal Could Lead to Increased Payments from MA Plans
Jan 10, 2025 07:39AM Needham Starts Privia Health Group Inc (PRVA) at Buy
Jan 7, 2025 06:41AM KeyBanc's Healthcare Services Outlook for 2025: 'EHC, ADUS, and PRVA Have the Best Potential to Grind Higher'
Dec 16, 2024 07:09AM Macquarie Starts Privia Health Group Inc (PRVA) at Outperform
Nov 7, 2024 06:18AM Privia Health Group, Inc. (PRVA) Tops Q3 EPS by 15c, provides guidance
Oct 11, 2024 05:38AM KeyBanc Starts Privia Health Group Inc (PRVA) at Overweight
Oct 1, 2024 06:27AM William Blair Reiterates Outperform Rating on Privia Health Group Inc (PRVA)
Aug 26, 2024 04:04PM Privia Health Group Inc (PRVA) PT Lowered to $27 at JPMorgan
Aug 26, 2024 06:59AM Privia Health Group Inc (PRVA) PT Raised to $24 at Baird
Aug 8, 2024 12:36PM Privia Health Group Inc (PRVA) PT Raised to $22 at Evercore ISI
Aug 8, 2024 06:11AM Privia Health Group, Inc. (PRVA) Tops Q2 EPS by 14c, raises guidance